VBI Vaccines Announces Dosing of First Recurrent GBM Patient in Part B of Ongoing Phase 1/2a Study of VBI-1901

July 29, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search